| 1 |
Moreno JD and Clancy CE (2012) Pathophysiology of the cardiac late Na current and its potential as a drug target. J Mol Cell Cardiol 52, 608-619
DOI
ScienceOn
|
| 2 |
Carvajal-Vergara X, Sevilla A, D'Souza SL et al (2010) Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 465, 808-812
DOI
ScienceOn
|
| 3 |
Lan F, Lee AS, Liang P et al (2013) Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell 12, 101-113
DOI
ScienceOn
|
| 4 |
Zhang SC, Wernig M, Duncan ID, Brüstle O and Thomson JA (2001) In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 19, 1129-1133
DOI
ScienceOn
|
| 5 |
Reubinoff BE, Itsykson P, Turetsky T et al (2001) Neural progenitors from human embryonic stem cells. Nat Biotechnol 19, 1134-1140
DOI
ScienceOn
|
| 6 |
Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M and Studer L. (2009) Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27, 275-280
DOI
ScienceOn
|
| 7 |
Kondo T, Asai M, Tsukita K et al (2013) Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Abeta and differential drug responsiveness. Cell Stem Cell 12, 487-496
DOI
ScienceOn
|
| 8 |
Yagi T, Ito D, Okada Y et al (2011) Modeling familial Alzheimer's disease with induced pluripotent stem cells. Hum Mol Genet 20, 4530-4539
DOI
ScienceOn
|
| 9 |
Wang H and Doering LC (2012) Induced pluripotent stem cells to model and treat neurogenetic disorders. Neural Plast 2012, 346053
|
| 10 |
Kaye JA and Finkbeiner S (2013) Modeling Huntington's disease with induced pluripotent stem cells. Mol Cell Neurosci 56, 50-64
DOI
ScienceOn
|
| 11 |
Israel MA, Yuan SH, Bardy C et al (2012) Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature 482, 216-220
DOI
|
| 12 |
Brennand KJ, Simone A, Jou J et al (2011) Modelling schizophrenia using human induced pluripotent stem cells. Nature 473, 221-225
DOI
ScienceOn
|
| 13 |
Ryan SD, Dolatabadi N, Chan SF et al (2013) Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1alpha transcription. Cell 155, 1351-1364
DOI
ScienceOn
|
| 14 |
Jeon I, Lee N, Li JY et al (2012) Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells. Stem Cells 30, 2054-2062
DOI
ScienceOn
|
| 15 |
Zhang K, Yi F, Liu GH and Izpisua Belmonte JC (2012) Huntington's disease: dancing in a dish. Cell Res 22, 1627-1630
DOI
|
| 16 |
Williams EC, Zhong X, Mohamed A et al (2014) Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons. Hum Mol Genet 23, 2968-2980
DOI
ScienceOn
|
| 17 |
Jeon I, Choi C, Lee N et al (2014) In Vivo Roles of a Patient-Derived Induced Pluripotent Stem Cell Line (HD72-iPSC) in the YAC128 Model of Huntington's Disease. Int J Stem Cells 7, 43-47
DOI
ScienceOn
|
| 18 |
Yang J, Cai J, Zhang Y et al (2010) Induced pluripotent stem cells can be used to model the genomic imprinting disorder Prader-Willi syndrome. J Biol Chem 285, 40303-40311
DOI
ScienceOn
|
| 19 |
Dajani R, Koo SE, Sullivan GJ and Park IH (2013) Investigation of Rett syndrome using pluripotent stem cells. J Cell Biochem 114, 2446-2453
DOI
ScienceOn
|
| 20 |
Sareen D, Ebert AD, Heins BM, McGivern JV, Ornelas L and Svendsen CN (2012) Inhibition of apoptosis blocks human motor neuron cell death in a stem cell model of spinal muscular atrophy. PLoS One 7, e39113
DOI
|
| 21 |
Ananiev G, Williams EC, Li H and Chang Q (2011) Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model. PLoS One 6, e25255
DOI
ScienceOn
|
| 22 |
Schöndorf DC, Aureli M, McAllister FE et al (2014) iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis. Nat Commun 5, 4028
|
| 23 |
Chamberlain SJ, Chen PF, Ng KY et al (2010) Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes. Proc Natl Acad Sci U S A 107, 17668-17673
DOI
ScienceOn
|
| 24 |
Egawa N and Inoue H (2013) [ALS disease modeling and drug screening using patient-specific iPS cells]. Rinsho Shinkeigaku 53, 1020-1022
DOI
|
| 25 |
Corti S, Nizzardo M, Simone C et al (2012) Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy. Sci Transl Med 4, 165ra162
DOI
ScienceOn
|
| 26 |
Ross CA and Akimov SS (2014) Human-induced pluripotent stem cells: potential for neurodegenerative diseases. Hum Mol Genet 23, R17-26
DOI
ScienceOn
|
| 27 |
Kiskinis E, Sandoe J, Williams LA et al (2014) Pathways Disrupted in Human ALS Motor Neurons Identified through Genetic Correction of Mutant SOD1. Cell Stem Cell 14, 781-795
DOI
ScienceOn
|
| 28 |
Chen H, Qian K, Du Z et al (2014) Modeling ALS with iPSCs Reveals that Mutant SOD1 Misregulates Neurofilament Balance in Motor Neurons. Cell Stem Cell 14, 796-809
DOI
ScienceOn
|
| 29 |
Wolstencroft EC, Mattis V, Bajer AA, Young PJ and Lorson CL (2005) A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels. Hum Mol Genet 14, 1199-1210
DOI
ScienceOn
|
| 30 |
Charbord J, Poydenot P, Bonnefond C et al (2013) High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes. Stem Cells 31, 1816-1828
DOI
|
| 31 |
Makhortova NR, Hayhurst M and Cerqueira A (2011) A screen for regulators of survival of motor neuron protein levels. Nat Chem Biol 7, 544-552
DOI
ScienceOn
|
| 32 |
Guo X, Disatnik MH, Monbureau M, Shamloo M, Mochly -Rosen D and Qi X (2013) Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration. J Clin Invest 123, 5371-5388
DOI
ScienceOn
|
| 33 |
Miller JD, Ganat YM, Kishinevsky S et al (2013) Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell 13, 691-705
DOI
ScienceOn
|
| 34 |
Kim C, Wong J, Wen J et al (2013) Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature 494, 105-110
DOI
ScienceOn
|
| 35 |
Reinhardt P, Schmid B, Burbulla LF et al (2013) Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell 12, 354-367
DOI
ScienceOn
|
| 36 |
Lopaschuk GD and Jaswal JS (2010) Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation. J Cardiovasc Pharmacol 56, 130-140
DOI
ScienceOn
|
| 37 |
Engler AJ, Carag-Krieger C, Johnson CP et al (2008) Embryonic cardiomyocytes beat best on a matrix with heartlike elasticity: scar-like rigidity inhibits beating. J Cell Sci 121, 3794-3802
DOI
ScienceOn
|
| 38 |
Djouadi F, Lecarpentier Y, Hébert JL, Charron P, Bastin J and Coirault C (2009) A potential link between peroxisome proliferator-activated receptor signalling and the pathogenesis of arrhythmogenic right ventricular cardiomyopathy. Cardiovasc Res 84, 83-90
DOI
ScienceOn
|
| 39 |
Choi SM, Kim Y, Shim JS et al (2013) Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells. Hepatology 57, 2458-2468
DOI
ScienceOn
|
| 40 |
Eroshenko N, Ramachandran R, Yadavalli VK and Rao RR (2013) Effect of substrate stiffness on early human embryonic stem cell differentiation. J Biol Eng 7, 7
DOI
ScienceOn
|
| 41 |
Galie PA, Khalid N, Carnahan KE, Westfall MV and Stegemann JP (2013) Substrate stiffness affects sarcomere and costamere structure and electrophysiological function of isolated adult cardiomyocytes. Cardiovasc Pathol 22, 219-227
DOI
ScienceOn
|
| 42 |
Hidvegi T, Ewing M, Hale P et al (2010) An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis. Science 329, 229-232
DOI
ScienceOn
|
| 43 |
Yang YM, Gupta SK, Kim KJ et al (2013) A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. Cell Stem Cell 12, 713-726
DOI
ScienceOn
|
| 44 |
Fermini B and Fossa AA (2003) The impact of drug-induced QT interval prolongation on drug discovery and development. Nat Rev Drug Discov 2, 439-447
DOI
ScienceOn
|
| 45 |
Liang P, Lan F, Lee AS et al (2013) Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation 127, 1677-1691
DOI
ScienceOn
|
| 46 |
Zeevi-Levin N, Itskovitz-Eldor J and Binah O (2012) Cardiomyocytes derived from human pluripotent stem cells for drug screening. Pharmacol Ther 134, 180-188
DOI
ScienceOn
|
| 47 |
Knollmann BC (2013) Induced pluripotent stem cell-derived cardiomyocytes: boutique science or valuable arrhythmia model? Circ Res 112, 969-976; discussion 976
DOI
ScienceOn
|
| 48 |
De Bruin ML, Pettersson M, Meyboom RH, Hoes AW and Leufkens HG (2005) Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death. Eur Heart J 26, 590-597
DOI
ScienceOn
|
| 49 |
Grant AO (2009) Cardiac ion channels. Circ Arrhythm Electrophysiol 2, 185-194
DOI
ScienceOn
|
| 50 |
Musunuru K (2013) Genome editing of human pluripotent stem cells to generate human cellular disease models. Dis Model Mech 6, 896-904
DOI
ScienceOn
|
| 51 |
Kim H and Kim JS (2014) A guide to genome engineering with programmable nucleases. Nat Rev Genet 15, 321-334
DOI
ScienceOn
|
| 52 |
Maeder ML, Linder SJ, Cascio VM, Fu Y, Ho QH and Joung JK (2013) CRISPR RNA-guided activation of endogenous human genes. Nat Methods 10, 977-979
DOI
ScienceOn
|
| 53 |
Qiang L, Fujita R and Abeliovich A (2013) Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders. Neuron 78, 957-969
DOI
ScienceOn
|
| 54 |
Wada R, Muraoka N, Inagawa K et al (2013) Induction of human cardiomyocyte-like cells from fibroblasts by defined factors. Proc Natl Acad Sci U S A 110, 12667-12672
DOI
ScienceOn
|
| 55 |
Munos B (2009) Lessons from 60 years of pharmaceutical innovation. Nat Rev Drug Discov 8, 959-968
DOI
ScienceOn
|
| 56 |
Fu JD, Stone NR, Liu L et al (2013) Direct Reprogramming of Human Fibroblasts toward a Cardiomyocyte-like State. Stem Cell Reports 1, 235-247
DOI
ScienceOn
|
| 57 |
Cerrone M, Lin X, Zhang M et al (2014) Missense mutations in plakophilin-2 cause sodium current deficit and associate with a brugada syndrome phenotype. Circulation 129, 1092-1103
DOI
ScienceOn
|
| 58 |
Seok J, Warren HS, Cuenca AG et al (2013) Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 110, 3507-3512
DOI
ScienceOn
|
| 59 |
Rajamohan D, Matsa E, Kalra S et al (2013) Current status of drug screening and disease modelling in human pluripotent stem cells. Bioessays 35, 281-298
DOI
ScienceOn
|
| 60 |
Rubin LL and Haston KM (2011) Stem cell biology and drug discovery. BMC Biol 9, 42
DOI
|
| 61 |
Park IH, Arora N, Huo H et al (2008) Disease-specific induced pluripotent stem cells. Cell 134, 877-886
DOI
ScienceOn
|
| 62 |
Takahashi K, Tanabe K, Ohnuki M et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872
DOI
ScienceOn
|
| 63 |
Takahashi K and Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676
DOI
ScienceOn
|
| 64 |
Ban H, Nishishita N, Fusaki N et al (2011) Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc Natl Acad Sci U S A 108, 14234-14239
DOI
ScienceOn
|
| 65 |
Kim C (2014) Disease modeling and cell based therapy with iPSC: future therapeutic option with fast and safe application. Blood Res 49, 7-14
DOI
ScienceOn
|
| 66 |
Mercola M, Ruiz-Lozano P, Schneider MD (2011) Cardiac muscle regeneration: lessons from development. Genes Dev 25, 299-309
DOI
ScienceOn
|
| 67 |
Yang L, Soonpaa MH, Adler ED et al (2008) Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453, 524-528
DOI
ScienceOn
|
| 68 |
Nascone N and Mercola M (1995) An inductive role for the endoderm in Xenopus cardiogenesis. Development 121, 515-523
|
| 69 |
Filipczyk AA, Passier R, Rochat A et al (2007) Regulation of cardiomyocyte differentiation of embryonic stem cells by extracellular signalling. Cell Mol Life Sci 64, 704-718
DOI
|
| 70 |
Kim C, Majdi M, Xia P et al (2010) Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation. Stem Cells Dev 19, 783-795
DOI
ScienceOn
|
| 71 |
Lian X, Hsiao C, Wilson G et al (2012) Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci U S A 109, E1848-1857
DOI
ScienceOn
|
| 72 |
Moretti A, Bellin M, Welling A et al (2010) Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 363, 1397-1409
DOI
ScienceOn
|
| 73 |
Itzhaki I, Maizels L, Huber I et al (2011) Modelling the long QT syndrome with induced pluripotent stem cells. Nature 471, 225-229
DOI
ScienceOn
|
| 74 |
Yazawa M, Hsueh B, Jia X et al (2011) Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 471, 230-234
DOI
ScienceOn
|
| 75 |
Ruan Y, Liu N, Napolitano C and Priori SG (2008) Therapeutic strategies for long-QT syndrome: does the molecular substrate matter? Circ Arrhythm Electrophysiol 1, 290-297
DOI
ScienceOn
|
| 76 |
Terrenoire C, Wang K, Tung KW et al (2013) Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics. J Gen Physiol 141, 61-72
DOI
|
| 77 |
Tabar V and Studer L (2014) Pluripotent stem cells in regenerative medicine: challenges and recent progress. Nat Rev Genet 15, 82-92
DOI
ScienceOn
|
| 78 |
Höing S, Rudhard Y, Reinhardt P et al (2012) Discovery of inhibitors of microglial neurotoxicity acting through multiple mechanisms using a stem-cell-based phenotypic assay. Cell Stem Cell 11, 620-632
DOI
ScienceOn
|
webmaster
